There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Morphosys Ag (MOR – Research Report), Abbott Labs (ABT – Research Report) and Inventiva (IVA – Research Report) with bullish sentiments.
Morphosys Ag (MOR)
Wells Fargo analyst Derek Archila maintained a Buy rating on Morphosys Ag yesterday and set a price target of $10.00. The company’s shares closed last Tuesday at $4.55.
According to TipRanks.com, Archila is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Morphosys Ag with a $11.36 average price target, representing a 140.2% upside. In a report issued on November 16, JMP Securities also reiterated a Buy rating on the stock with a $17.00 price target.
See today’s best-performing stocks on TipRanks >>
Abbott Labs (ABT)
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Labs yesterday and set a price target of $116.00. The company’s shares closed last Tuesday at $101.91.
According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Abbott Labs with a $118.00 average price target.
Inventiva (IVA)
In a report released today, Annabel Samimy from Stifel Nicolaus maintained a Buy rating on Inventiva, with a price target of $27.00. The company’s shares closed last Tuesday at $4.06.
According to TipRanks.com, Samimy is a 5-star analyst with an average return of
Currently, the analyst consensus on Inventiva is a Strong Buy with an average price target of $25.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on MOR:
